Insights from CPHI Milan 2026
October 6–8, 2026: Milan becomes the beating heart of the global pharmaceutical industry.
During CPHI Milan 2026, Teknoscienze interviewed Andy Sheldon, CEO of the Biologics Manufacturing Centre (BMC), to explore Canada’s growing role in the global biomanufacturing landscape and the opportunities for international collaboration.
Andy Sheldon
Drawing on more than four decades of experience in the pharmaceutical and biotechnology sectors, Andy Sheldon discusses how BMC supports Canadian and international biotechnology companies through technical expertise, training and access to manufacturing infrastructure.
The conversation explores the challenges of moving innovative therapies from research and development to large-scale manufacturing, the importance of funding and strategic partnerships, and Canada’s ambitions to strengthen its biomanufacturing capacity, supply chain resilience and position as a global partner.
For more information about CPHI Milan and upcoming editions, visit the official event website.
